Study on early efficacy of UBED and PEID in the treatment of L5/S1 intervertebral disc herniation.

IF 1.7 4区医学 Q2 SURGERY

Minimally Invasive Therapy & Allied Technologies Pub Date : 2024-02-01 Epub Date: 2024-02-02 DOI:10.1080/13645706.2023.2278059

Xian He, Haidong Yin, Yantao Wang, Taibin Qiu, Kunhua Zeng, Juncheng Liu

{"title":"Study on early efficacy of UBED and PEID in the treatment of L5/S1 intervertebral disc herniation.","authors":"Xian He, Haidong Yin, Yantao Wang, Taibin Qiu, Kunhua Zeng, Juncheng Liu","doi":"10.1080/13645706.2023.2278059","DOIUrl":null,"url":null,"abstract":"Introduction: This study aimed to compare early efficacy of UBED and PEID in the treatment of L5/S1 IDH.Material and methods: Forty-two patients who underwent surgical treatment for L5/S1 IDH were divided into two groups: UBED and PEID. Operation time, complications, VAS/ODI score were recorded. MacNab evaluation was completed one and three months postoperatively.Results: All patients were successfully operated without infection, nerve injury, or huge hematoma in the spinal canal. There were no significant differences in operation time and hospitalization days between the two groups (p > 0.05). All patients were followed up after the operation and low back/leg pain was significantly reduced. VAS for low back pain, VAS for leg pain, ODI scores in both groups one and three months after the operation were significantly lower than pre-operation (p < 0.05). There were no significant differences between one and three months after the operation in both groups (p > 0.05). There were no significant differences in VAS for low back pain, leg pain, ODI score, and overall efficacy between the two groups one and three months post-operation (p > 0.05).Conclusion: UBED and PEID have very good early efficacy in treating L5/S1 IDH. Because UBED has a wider vision field and more flexible operation, it can be used as a useful complement to PEID.","PeriodicalId":18537,"journal":{"name":"Minimally Invasive Therapy & Allied Technologies","volume":" ","pages":"43-50"},"PeriodicalIF":1.7000,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Minimally Invasive Therapy & Allied Technologies","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/13645706.2023.2278059","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/2/2 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"SURGERY","Score":null,"Total":0}

引用次数: 0

Abstract

Introduction: This study aimed to compare early efficacy of UBED and PEID in the treatment of L5/S1 IDH.

Material and methods: Forty-two patients who underwent surgical treatment for L5/S1 IDH were divided into two groups: UBED and PEID. Operation time, complications, VAS/ODI score were recorded. MacNab evaluation was completed one and three months postoperatively.

Results: All patients were successfully operated without infection, nerve injury, or huge hematoma in the spinal canal. There were no significant differences in operation time and hospitalization days between the two groups (p > 0.05). All patients were followed up after the operation and low back/leg pain was significantly reduced. VAS for low back pain, VAS for leg pain, ODI scores in both groups one and three months after the operation were significantly lower than pre-operation (p < 0.05). There were no significant differences between one and three months after the operation in both groups (p > 0.05). There were no significant differences in VAS for low back pain, leg pain, ODI score, and overall efficacy between the two groups one and three months post-operation (p > 0.05).

Conclusion: UBED and PEID have very good early efficacy in treating L5/S1 IDH. Because UBED has a wider vision field and more flexible operation, it can be used as a useful complement to PEID.

查看原文本刊更多论文

UBED和PEID治疗L5/S1椎间盘突出症的早期疗效研究。

引言：本研究旨在比较UBED和PEID治疗L5/S1 IDH的早期疗效。材料和方法：42例接受L5/S1 ID手术治疗的患者分为两组：UBED和PEID。记录手术时间、并发症、VAS／ODI评分。MacNab评估在术后一个月和三个月完成。结果：所有患者均成功手术，无感染、神经损伤或椎管内巨大血肿。两组患者手术时间和住院天数差异无统计学意义（p > 0.05）。所有患者术后均进行了随访，腰痛/腿痛明显减轻。术后1个月和3个月两组的腰痛VAS、腿痛VAS、ODI评分均显著低于术前（p p > 术后1个月和3个月，两组在腰痛、腿痛、ODI评分和总疗效方面的VAS评分无显著差异（p > 结论：UBED和PEID治疗L5/S1 IDH具有良好的早期疗效。由于UBED具有更宽的视野和更灵活的操作，它可以作为PEID的有用补充。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Minimally Invasive Therapy & Allied Technologies 医学-外科

CiteScore

3.80

自引率

5.90%

发文量

审稿时长

6-12 weeks

期刊介绍： Minimally Invasive Therapy and Allied Technologies (MITAT) is an international forum for endoscopic surgeons, interventional radiologists and industrial instrument manufacturers. It is the official journal of the Society for Medical Innovation and Technology (SMIT) whose membership includes representatives from a broad spectrum of medical specialities, instrument manufacturing and research. The journal brings the latest developments and innovations in minimally invasive therapy to its readers. What makes Minimally Invasive Therapy and Allied Technologies unique is that we publish one or two special issues each year, which are devoted to a specific theme. Key topics covered by the journal include: interventional radiology, endoscopic surgery, imaging technology, manipulators and robotics for surgery and education and training for MIS.